A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy

BACKGROUND AND OBJECTIVES: Eslicarbazepine acetate (ESL) is a third-generation anti-seizure medication for patients with focal-onset epilepsy. There are known short-term impacts of classic enzyme-inducing drugs on bone health. For oxcarbazepine, which like ESL is a less potent inducer of cytochrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirsch, Martin, Immisch, Ilka, Knake, Susanne, Schulze-Bonhage, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667382/
https://www.ncbi.nlm.nih.gov/pubmed/37921919
http://dx.doi.org/10.1007/s40263-023-01045-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667382/
https://www.ncbi.nlm.nih.gov/pubmed/37921919
http://dx.doi.org/10.1007/s40263-023-01045-0

Ejemplares similares